Kernal Biologics specializes in developing mRNA therapies to treat severe diseases such as cancer. Leveraging expertise from MIT, Harvard, and Big Pharma, Kernal utilizes synthetic biology and RNA design to create innovative immunotherapies. The company's distinctive approach involves programming cells to produce their own drugs, offering a promising new frontier in medical treatment.
Kernal Bio is a biotech company revolutionizing mRNA therapeutics with AI-designed oligonucleotides. They seek an exceptional Principal Scientist to contribute to a target lipid nanoparticle platform, supporting manufacturing, transferring technology, and analyzing results in a fast-paced environment. The role involves developing and characterizing LNP formulations, optimizing manufacturing processes, and collaborating with external partners.
Kernal Biologics specializes in developing mRNA therapies to treat severe diseases such as cancer. Leveraging expertise from MIT, Harvard, and Big Pharma, Kernal utilizes synthetic biology and RNA design to create innovative immunotherapies. The company's distinctive approach involves programming cells to produce their own drugs, offering a promising new frontier in medical treatment.
Kernal Biologics